Kula Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Kula Investments’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,137	Closed	-$469K	–	925
2022 Q4	$469K	Buy	+14,137	New	+$455K	0.14%	232

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kula Investments's VIVO Position: Q1 2023 in Review

Kula Investments sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 14,137 shares — an estimated $469K sold.

Kula Investments first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $469K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Kula Investments reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Kula Investments sold 14,137 Meridian Bioscience Inc shares in Q1 2023, an estimated $469K.
Kula Investments first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Kula Investments's Meridian Bioscience Inc position peaked at $469K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.